样式: 排序: IF: - GO 导出 标记为已读
-
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2024-03-01 Eunhye Seo, Yeongkeun Kwon, Ahmad ALRomi, Mohannad Eledreesi, Sungsoo Park
-
Diagnosis and management of secondary adrenal crisis Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2024-02-27 Luciana Martel-Duguech, Jonathan Poirier, Isabelle Bourdeau, André Lacroix
-
The changing landscape of acromegaly – an epidemiological perspective Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2024-02-10 Christian Rosendal, Mai Christiansen Arlien-Søborg, Eigil Husted Nielsen, Marianne Skovsager Andersen, Claus Larsen Feltoft, Caroline Kistorp, Olaf M. Dekkers, Jens Otto Lunde Jørgensen, Jakob Dal
-
Subclinical central hypothyroidism in patients with hypothalamic-pituitary disease: does it exist? Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2024-02-07 Julio Abucham, Manoel Martins
-
Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2024-02-05 Daniel de Luis Román, Juana Carretero Gómez, José Manuel García-Almeida, Fernando Garrachón Vallo, German Guzmán Rolo, Juan José López Gómez, Francisco José Tarazona-Santabalbina, Alejandro Sanz-Paris
-
Adrenal insufficiency in liver diseases - pathophysiology and underlying mechanisms Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2024-02-02 Maria Kalafateli, Ioanna Aggeletopoulou, Christos Triantos
-
Special features on insulin resistance, metabolic syndrome and vascular complications in hypopituitary patients Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2024-01-25 Heraldo M Garmes
-
Androgen deficiency in hypopituitary women: its consequences and management Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2024-01-19 Daniela Esposito, Åsa Tivesten, Catharina Olivius, Oskar Ragnarsson, Gudmundur Johannsson
-
The effect of bariatric surgery on the expression of gastrointestinal taste receptors: A systematic review Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2024-01-11
Abstract Gastrointestinal nutrient sensing via taste receptors may contribute to weight loss, metabolic improvements, and a reduced preference for sweet and fatty foods following bariatric surgery. This review aimed to investigate the effect of bariatric surgery on the expression of oral and post-oral gastrointestinal taste receptors and associations between taste receptor alterations and clinical
-
Pulling the trigger: Noncoding RNAs in white adipose tissue browning Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-29
Abstract White adipose tissue (WAT) serves as the primary site for energy storage and endocrine regulation in mammals, while brown adipose tissue (BAT) is specialized for thermogenesis and energy expenditure. The conversion of white adipocytes to brown-like fat cells, known as browning, has emerged as a promising therapeutic strategy for reversing obesity and its associated co-morbidities. Noncoding
-
Diagnosing and treating the elderly individual with hypopituitarism Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-27 Andrea Corsello, Rosa Maria Paragliola, Roberto Salvatori
-
Cognition and psychological wellbeing in hypopituitary patients Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-26 Syed Ali Imran, Michael Wilkinson
Hypopituitarism (HP) frequently occurs in patients presenting with sellar masses and despite recent advances in therapeutic options, HP patients consistently suffer from impaired quality of life due to psychological distress and cognitive dysfunction. These neurocognitive complications tend to persist in spite of surgical or biochemical remission of the disease making it especially challenging to segregate
-
Correction to: Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-22 Rexhina Vlashi, Xingen Zhang, Haibo Li, Guiqian Chen
-
Diagnosing and treating anterior pituitary hormone deficiency in pediatric patients Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-19 Rodolfo A. Rey, Ignacio Bergadá, María Gabriela Ballerini, Débora Braslavsky, Ana Chiesa, Analía Freire, Romina P. Grinspon, Ana Keselman, Andrea Arcari
-
The genetics of Graves’ disease Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-18 Lydia Grixti, Laura C. Lane, Simon H Pearce
-
New insights on diagnosis and treatment of AVP deficiency Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-13 Julie Refardt, Cihan Atila, Mirjam Christ-Crain
-
Role of CaMKII in diabetes induced vascular injury and its interaction with anti-diabetes therapy Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-08 Stephanie Chacar, Abdulhamid Abdi, Khalifa Almansoori, Jawaher Alshamsi, Cynthia Al Hageh, Pierre Zalloua, Ali A. Khraibi, Stephen G. Holt, Moni Nader
-
New findings on brain actions of growth hormone and potential clinical implications Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-07 Jose Donato, John J. Kopchick
-
Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-06 Rexhina Vlashi, Xingen Zhang, Haibo Li, Guiqian Chen
-
Association between protein undernutrition and diabetes: Molecular implications in the reduction of insulin secretion Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-04 Thiago dos Reis Araujo, Bruna Lourençoni Alves, Lohanna Monali Barreto dos Santos, Luciana Mateus Gonçalves, Everardo Magalhães Carneiro
-
An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-05 Zeinab Ghesmati, Mohsen Rashid, Shabnam Fayezi, Frank Gieseler, Effat Alizadeh, Masoud Darabi
-
Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-05 Rosaria M. Ruggeri, Irene Aini, Stefano Gay, Erika Maria Grossrubatscher, Camilla Mancini, Maria Grazia Tarsitano, Virginia Zamponi, Andrea M. Isidori, Annamaria Colao, Antongiulio Faggiano
-
New insights in thyroid diagnosis and treatment Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-02 Fabian Pitoia, Pierpaolo Trimboli
The prevalence of thyroid disease continues to rise. As a consequence, the research in the thyroid field has significantly increased over time. Thus, clinicians, and endocrinologists first, have to be aware of the important continuous progress achieved, in particular of thyroid cancer, to better manage their patients. This themed issue, titled “New Insights in Thyroid Diagnosis and Treatment,” delves
-
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-12-02 Lucas Paulo Jacinto Saavedra, Silvano Piovan, Veridiana Mota Moreira, Gessica Dutra Gonçalves, Anna Rebeka Oliveira Ferreira, Maiara Vanusa Guedes Ribeiro, Maria Natália Chimirri Peres, Douglas Lopes Almeida, Scarlett Rodrigues Raposo, Mariane Carneiro da Silva, Letícia Ferreira Barbosa, Paulo Cezar de Freitas Mathias
-
Dynamic risk assessment in patients with differentiated thyroid cancer Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-11-28 Erika Abelleira, Fernando Jerkovich
-
Current practice in intermediate risk differentiated thyroid cancer – a review Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-11-23 Rosalia do Prado Padovani, Fernanda Barbosa Duarte, Camila Nascimento
-
Circadian alignment of food intake and glycaemic control by time-restricted eating: A systematic review and meta-analysis Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-11-22 Susana Rovira-Llopis, Clara Luna-Marco, Laura Perea-Galera, Celia Bañuls, Carlos Morillas, Victor M. Victor
-
Thyroid cancer and insulin resistance Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-11-14 Gabriela Brenta, Fernando Di Fermo
-
Thyroid ultrasound and its ancillary techniques Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-11-10 Joerg Bojunga, Pierpaolo Trimboli
-
Molecular testing for thyroid nodules: Where are we now? Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-10-30 Carolina Ferraz
-
Clinical and molecular impact of concurrent thyroid autoimmune disease and thyroid cancer: From the bench to bedside Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-10-27 Victor Alexandre dos Santos Valsecchi, Felipe Rodrigues Betoni, Laura Sterian Ward, Lucas Leite Cunha
-
Hypoprolactinemia. Does it matter? Redefining the hypopituitarism and return from a mumpsimus Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-10-25 Zuleyha Karaca, Kursad Unluhizarci, Fahrettin Kelestimur
-
Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-10-24 Maria Sharmila Alina de Sousa, Isabela Nogueira Nunes, Yasmin Paz Christiano, Luiza Sisdelli, Janete Maria Cerutti
-
Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-10-16 Muthukumaran Jayachandran, Shen Qu
-
Thirty years of active surveillance for low-risk thyroid cancer, lessons learned and future directions Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-10-14 Anabella Smulever, Fabian Pitoia
-
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-10-13 Elena Russo, Mathilda Guizzardi, Luca Canali, Francesca Gaino, Andrea Costantino, Gherardo Mazziotti, Andrea Lania, Silvia Uccella, Luca Di Tommaso, Fabio Ferreli, Luca Malvezzi, Giuseppe Spriano, Giuseppe Mercante
-
The relationship between thyroid and human-associated microbiota: A systematic review of reviews Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-10-12 Camilla Virili, Ilaria Stramazzo, Maria Flavia Bagaglini, Anna Lucia Carretti, Silvia Capriello, Francesco Romanelli, Pierpaolo Trimboli, Marco Centanni
-
Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-10-11 Jesús M. Pérez-Gómez, Antonio J. Montero-Hidalgo, Antonio C. Fuentes-Fayos, André Sarmento-Cabral, Rocio Guzmán-Ruiz, María M. Malagón, Aura D. Herrera-Martínez, Manuel D. Gahete, Raúl M. Luque
-
Does it work in childhood and adolescence? The predictive role of postoperative/preablative stimulated thyroglobulin levels in paediatric thyroid cancer. A systematic review of the literature Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-09-25 Arnoldo Piccardo, Francesco Fiz, Gianluca Bottoni, Luca Foppiani, Domenico Albano, Francesco Bertagna, Ugo Catrambone, Federica Mariani, Beatrice Sambucco, Michela Massollo, Giorgio Treglia, Pierpaolo Trimboli
-
Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-09-16 Alessio Imperiale, Valentina Berti, Mickaël Burgy, Roberto Luigi Cazzato, Arnoldo Piccardo, Giorgio Treglia
-
Childhood obesity, metabolic syndrome, and oxidative stress: microRNAs go on stage Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-09-06 Álvaro González-Domínguez, Thalía Belmonte, Raúl González-Domínguez
-
Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-09-04 Andrea Giustina, Luigi di Filippo, Antonio Facciorusso, Robert A. Adler, Neil Binkley, Jens Bollerslev, Roger Bouillon, Felipe F. Casanueva, Giulia Martina Cavestro, Marlene Chakhtoura, Caterina Conte, Lorenzo M. Donini, Peter R. Ebeling, Angelo Fassio, Stefano Frara, Claudia Gagnon, Giovanni Latella, Claudio Marcocci, Jeffrey I. Mechanick, Salvatore Minisola, René Rizzoli, Ferruccio Santini, Joseph
-
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-08-31 Inés Califano, Anabella Smulever, Fernando Jerkovich, Fabian Pitoia
-
Efficacy of antiresorptive agents in fibrous dysplasia and McCune Albright syndrome, a systematic review and meta-analysis Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-08-26 Hélios Bertin, Mahmoud S. Moussa, Svetlana Komarova
-
Metabolic phenotyping in people living with obesity: Implications for dietary prevention Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-08-15 Ellen E. Blaak, Gijs H. Goossens
-
White adipose tissue mitochondrial bioenergetics in metabolic diseases Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-08-10 Rugivan Sabaratnam, Didde Riisager Hansen, Per Svenningsen
-
Drug-induced hyperinsulinemic hypoglycemia: An update on pathophysiology and treatment Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-08-08 Evelina Maines, Silvana Anna Maria Urru, Letizia Leonardi, Elisabetta Fancellu, Annalisa Campomori, Giovanni Piccoli, Arianna Maiorana, Massimo Soffiati, Roberto Franceschi
-
Phenotyping the obesities: reality or utopia? Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-08-04 Piero Portincasa, Gema Frühbeck
-
Beyond glycemia: Comparing tirzepatide to GLP-1 analogues Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-08-01 John Andraos, Harleen Muhar, Shawn R. Smith
-
The kisspeptin system in and beyond reproduction: exploring intricate pathways and potential links between endometriosis and polycystic ovary syndrome Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-07-28 Noemi Salmeri, Paola Viganò, Paolo Cavoretto, Roberto Marci, Massimo Candiani
-
Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: A systematic review Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-07-26 Mafalda V. Moreira, Emídio Vale-Fernandes, Inês C. Albergaria, Marco G. Alves, Mariana P. Monteiro
-
Phase angle as a marker of outcome in hospitalized pediatric patients. A systematic review of the evidence (GRADE) with meta-analysis Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-07-24 Rocío Fernández-Jiménez, Rafael Martín-Masot, Isabel Cornejo-Pareja, Isabel M. Vegas-Aguilar, Marta Herrador-López, Francisco J. Tinahones, Víctor Manuel Navas-López, Diego Bellido-Guerrero, José Manuel García-Almeida
-
Towards precision medicine in non-alcoholic fatty liver disease Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-07-21 Sven M. Francque
-
Postprandial plasma GLP-1 levels are elevated in individuals with postprandial hypoglycaemia following Roux-en-Y gastric bypass – a systematic review Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-07-13 Ryan Joseph Jalleh, Mahesh Michael Umapathysivam, Mark Philip Plummer, Adam Deane, Karen Louise Jones, Michael Horowitz
-
Ectopic insulinoma: a systematic review Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-07-12 Fernando Guerrero-Pérez, Nuria Vilarrasa, Lidia V. Huánuco, Juli Busquets, Lluis Secanella, José L. Vercher-Conejero, Noemi Vidal, Silvia Näf Cortés, Carles Villabona
-
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-07-12 Francesco Dondi, Roberto Gatta, Giorgio Treglia, Arnoldo Piccardo, Domenico Albano, Luca Camoni, Elisa Gatta, Maria Cavadini, Carlo Cappelli, Francesco Bertagna
-
Targeting aging with the healthy skeletal system: The endocrine role of bone Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-07-05 Xuan-Qi Zheng, Jia-Liang Lin, Jie Huang, Tong Wu, Chun-Li Song
-
Precision nutrition for targeting pathophysiology of cardiometabolic phenotypes Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-07-05 Christopher E. Shannon, Méabh B. Ní Chathail, Sinéad M. Mullin, Andrew Meehan, Fiona C. McGillicuddy, Helen M. Roche
-
Management of radioiodine refractory differentiated thyroid cancer: the Latin American perspective Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-06-29 Fabian Pitoia, Rafael Selbach Scheffel, Ines Califano, Alicia Gauna, Hernán Tala, Fernanda Vaisman, Alejandro Roman Gonzalez, Ana Oliveira Hoff, Ana Luiza Maia
Radioiodine (RAI) refractory differentiated thyroid cancer is an uncommon and challenging situation that requires a multidisciplinary approach to therapeutic strategies. The definition of RAI-refractoriness is usually a clear situation in specialized centers. However, the right moment for initiation of multikinase inhibitors (MKI), the time and availability for genomic testing, and the possibility
-
Hidden chronic metabolic acidosis of diabetes type 2 (CMAD): Clues, causes and consequences Rev. Endocr. Metab. Disord. (IF 8.2) Pub Date : 2023-06-28 Hayder A. Giha